Delivery Order SPE2DB24D1205-SPE2DB25FDAUD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,310.96 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. AmerisourceBergen will perform the work from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical supplier within the federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,113.51 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader relationship with the federal government as a major...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,714.50 to AmerisourceBergen Drug Corp for PROLIA 60 mg/ml syringes, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Prolia 60 mg/mL syringes, valued at $11,629.70. This is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order under a larger...
- The Defense Logistics Agency awarded a $35,094.09 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $18,350.75 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price contract was competitively awarded on August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $7,547.18 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $15,697.68 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,746.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Prolia 60 mg/ml syringes. The contract, designated as a non-set-aside competitive award, is scheduled for ultimate completion by April 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAUDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,122.57 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of September 23, 2025. This competitively awarded contract employs firm fixed pricing and represents a non-set-aside procurement. The award was made to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, which serves as a critical pharmaceutical and medical supply vendor for federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to meet competitive procurement requirements across a diverse range of pharmaceutical products, positioning the company as a key supplier for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 9/22/25 |